Dana-Farber - Harvard Cancer Center LAO — Boston, Massachusetts

Dana-Farber - Harvard Cancer Center LAO is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Dana-Farber - Harvard Cancer Center LAO has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Refractory Myelodysplastic Syndrome, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber - Harvard Cancer Center LAO?

Dana-Farber - Harvard Cancer Center LAO has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber - Harvard Cancer Center LAO conducted?

Dana-Farber - Harvard Cancer Center LAO has 2 clinical trials on record, with 1 currently active. Their work covers Refractory Myelodysplastic Syndrome, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8.

Is Dana-Farber - Harvard Cancer Center LAO accredited by Crixeo Health?

Dana-Farber - Harvard Cancer Center LAO has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber - Harvard Cancer Center LAO?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.